MarketPeel
Insider Trading Intelligence
SK

Shane William Charles Kovacs

OLMA
CH. OPERATING & FINANCIAL OFF. · OLEMA PHARMACEUTICALS, INC. · CIK 0001579397
FILING MIX · LIFETIME50%/50%
BUYS
13
SELLS
13
TOTAL VALUE
$4.16M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
139,727
AVG SELL PX
$22.61
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Shane William Charles Kovacs, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+100.00%-8.74%-0.42%-8.32%-4.94%
14d10+100.00%-10.03%+0.00%-10.04%-10.40%
30d10+80.00%-8.26%-0.48%-7.78%-11.66%
60d10+100.00%-17.90%+1.51%-19.42%-32.99%
90d10+60.00%-7.47%+1.96%-9.43%-31.25%
180d10(2 pending)+100.00%+1.30%+7.13%-5.82%-47.68%
1y10(2 pending)+62.50%+134.26%+23.11%+111.15%+192.78%
2y10(5 pending)+20.00%+83.47%+43.27%+40.20%+8.16%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OLMA · 139,727 shares · as of Jan 15, 2026
0144,677289,354434,031578,708202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 13 buys / 13 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
100,000$28.73$2.87M139,727Jan 15, 2026Jan 15, 2026View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
3,822$28.01$107.1K239,727Jan 13, 2026Jan 15, 2026View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALEGRANT
Gift
75,000243,549Dec 8, 2025Dec 9, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALEGRANT
Gift
225,000318,549Nov 26, 2025Dec 1, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
320,000320,000Feb 28, 2025Mar 3, 2025View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
17,950$8.66$155.4K543,955Dec 11, 2024Dec 11, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
406$9.39$3.8K543,549Dec 11, 2024Dec 11, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
16,803$9.37$157.4K561,905Dec 10, 2024Dec 11, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
68,250578,708Dec 9, 2024Dec 11, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
Ch. Operating & Financial Off.
25,000162,000Nov 15, 2024Nov 17, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
Ch. Operating & Financial Off.
25,000$7.02$175.5K510,458Nov 15, 2024Nov 17, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
304,500304,500Feb 1, 2024Feb 5, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
50,000187,000Jan 12, 2024Jan 16, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
CH. OPERATING & FINANCIAL OFF.
50,000$7.02$351.0K484,987Jan 12, 2024Jan 16, 2024View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
CH. OPERATING & FINANCIAL OFF.
10,000$7.02$70.2K434,987Dec 12, 2023Dec 12, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
10,000237,000Dec 12, 2023Dec 12, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
9,145$13.89$127.0K424,987Nov 22, 2023Nov 22, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
8,897$14.83$131.9K434,832Nov 21, 2023Nov 22, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
SALE
CH. OPERATING & FINANCIAL OFF.
700$15.27$10.7K434,132Nov 21, 2023Nov 22, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,750443,729Nov 20, 2023Nov 22, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
CH. OPERATING & FINANCIAL OFF.
10,000396,197Apr 6, 2023Apr 7, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
200,000200,000Feb 1, 2023Feb 2, 2023View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASE
CH. OPERATING & FINANCIAL OFF.
20,000381,197Sep 2, 2022Sep 6, 2022View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
247,000247,000Feb 1, 2022Feb 3, 2022View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
107,604107,604Nov 18, 2020Nov 19, 2020View →
OLMA
OLEMA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
358,680358,680Jun 15, 2020Nov 19, 2020View →
Other insiders · OLMA
Loading peer insiders…
About this filer
CIK 0001579397
ROLE
CH. OPERATING & FINANCIAL OFF.
PRIMARY
OLMA
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001579397DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback